IRadimed Corp reports results for the quarter ended in June - Earnings Summary

IRADIMED

01/08/2024 15:11

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
42 cents​​ per share for the quarter ended in June, higher than
the same quarter last year, when the company reported EPS of 36
cents.  The mean expectation of two analysts for the quarter was
for earnings of 37 cents per share. Wall Street expected
results to range from 36 cents to 37 cents per share.
    * Revenue rose 11.1% to $17.93 million from a year ago;
analysts
expected $17.65 million. 
    * IRadimed Corp's reported EPS for the quarter was 38
cents​.
    * The company reported quarterly net income of $4.9 million.
    * IRadimed Corp shares had risen by 6.3% this quarter and
lost 1.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for IRadimed Corp is
$62.50 
This summary was machine generated from LSEG data August 1 at
02:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.37           0.42           Beat
 Mar. 31 2024      0.34           0.36           Beat
 Dec. 31 2023      0.40           0.39           Missed
 Sep. 30 2023      0.36           0.43           Beat